Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
ALL MEDICAL CODES IN CATEGORY Injection

2025 HCPCS code J9351

Supply of 0.1 mg of intravenous topotecan injection.

2025 HCPCS code Q5121

Injection, infliximab-axxq (Avsola), 10 mg; a biosimilar to Remicade.

2025 HCPCS code J9230

Mechlorethamine hydrochloride (nitrogen mustard) injection, 10 mg.

2025 HCPCS code J9274

Injection, tebentafusp-tebn, 1 microgram.

2025 HCPCS code J9100

This HCPCS code represents 100 mg of cytarabine, a chemotherapy drug, for injection (IV or subcutaneous).

2025 HCPCS code J9247

This HCPCS code represents 1 mg of melphalan flufenamide, an anticancer drug administered intravenously.

2025 HCPCS code J9320

Streptozocin injection, 1 gram;This code represents the supply of the drug only, not its administration.

2025 HCPCS code J9179

Eribulin mesylate injection; 0.1 mg.

2025 HCPCS code J2502

Injection of 1 mg of long-acting pasireotide.

2025 CPT code 0213T

Injection of a diagnostic or therapeutic agent into a single cervical or thoracic paravertebral facet joint (or its innervating nerves) under ultrasound guidance.

2025 CPT code 64494

Injection of diagnostic or therapeutic agent into lumbar or sacral paravertebral facet joint (or nerves innervating that joint) with image guidance; second level.

2025 HCPCS code J9354

Ado-trastuzumab emtansine (1 mg) injection for intravenous administration.

2025 HCPCS code J9313

One unit of J9313 represents 0.01 mg of moxetumomab pasudotox-tdfk administered intravenously to treat relapsed or refractory hairy cell leukemia in adults.

2025 HCPCS code J9333

This HCPCS code represents 1 mg of rozanolixizumab-noli, a drug administered subcutaneously to treat generalized myasthenia gravis.

2025 HCPCS code J9393

Injection, fulvestrant (Teva), 25 mg; not therapeutically equivalent to J9395.

2025 HCPCS code J0592

Supply of 0.1 mg buprenorphine hydrochloride for deep intramuscular or slow intravenous injection.

2025 HCPCS code J9356

One unit of J9356 represents 10 mg of trastuzumab and hyaluronidase-oysk administered subcutaneously for HER2-positive breast and gastric cancers.

2025 HCPCS code J0641

This HCPCS code represents 0.5 mg of levoleucovorin administered intravenously.

2025 HCPCS code J2020

Injection of linezolid, 200 mg.

2025 HCPCS code J9190

500 mg of fluorouracil injection for chemotherapy.

2025 HCPCS code J9357

Valrubicin, intravesical, 200 mg injection.

2025 HCPCS code J9021

This HCPCS code represents 0.1 mg of recombinant asparaginase (Rylaze), administered via intramuscular injection to treat leukemia and lymphoma.

2025 HCPCS code J9228

Injection, ipilimumab, 1 mg.

2025 HCPCS code J9306

J9306 represents 1 mg of pertuzumab injection.

2025 HCPCS code J9155

Degarelix injection, up to 1 mg.

2025 HCPCS code J9223

One unit of J9223 represents 0.1 mg of lurbinectedin, an intravenous anticancer drug for metastatic small cell lung cancer.

2025 HCPCS code J9205

J9205 represents 1 mg of irinotecan liposome injection, used in treating pancreatic adenocarcinoma.

2025 HCPCS code J9023

This code represents 10 mg of avelumab, a monoclonal antibody used in intravenous infusion for treating metastatic Merkel cell carcinoma (MCC) and other cancers.

2025 HCPCS code J1627

Supply of 0.1 mg of extended-release granisetron injection for chemotherapy-induced nausea and vomiting prevention.

2025 HCPCS code J9302

Injection of ofatumumab, 10 mg.

2025 HCPCS code Q5121

Inyección, infliximab-axxq (Avsola), 10 mg; un biosimilar a Remicade.

2025 HCPCS code Q5121

Injektion, Infliximab-Axxq (Avsola), 10 mg; ein Biosimilar zu Remicade.

2025 HCPCS code Q5121

Injection, infliximab-axxq (Avsola), 10 mg; isang biosimilar sa Remicade.

2025 HCPCS code Q5121

حقن، إنفليكسيماب-axxq (أفسولا)، 10 ملغ؛ وهو بديل حيوي لريميكاد.

2025 HCPCS code Q5121

注射剂,infliximab-axxq(Avsola),10 mg;Remicade 的生物仿制药。

2025 HCPCS code Q5121

Инъекция, инфликсимаб-axxq (Avsola), 10 мг; биоаналог Ремикейда.

2025 HCPCS code Q5121

Tiêm, infliximab-axxq (Avsola), 10 mg; một chất tương tự sinh học với Remicade.

2025 HCPCS code Q5121

주사제, 인플릭시맙-악스큐 (Avsola), 10mg, 레미케이드의 바이오시밀러.

2025 HCPCS code Q5121

Injection, infliximab-axxq (Avsola), 10 mg ; un biosimilaire au Remicade.

2025 HCPCS code J9267

该HCPCS代码表示静脉注射所需的1 mg紫杉醇的供应。

2025 HCPCS code J3000

Injection, streptomycin, up to 1 gram

2025 HCPCS code J9352

This HCPCS code represents the supply of 0.1 mg of trabectedin, a chemotherapy drug used to treat certain types of sarcoma.

2025 HCPCS code J9022

This HCPCS code represents 10 mg of atezolizumab (Tecentriq), a monoclonal antibody administered intravenously for treating various cancers, including bladder cancer.

2025 HCPCS code J9267

This HCPCS code represents the supply of 1 mg of paclitaxel for intravenous administration.

2025 HCPCS code J2212

Injection of methylnaltrexone, 0.1 mg, to treat opioid-induced constipation.

2025 HCPCS code J9177

J9177 represents a 0.25 mg injection of enfortumab vedotin-ejfv, a cytotoxic drug used intravenously to treat specific urothelial cancers.

2025 HCPCS code J2250

This HCPCS code represents the supply of midazolam hydrochloride injection, per 1 mg.

2025 HCPCS code J9260

This HCPCS code represents the supply of 50 mg of methotrexate sodium, a medication used to treat various cancers, psoriasis, and rheumatoid arthritis.

2025 HCPCS code J9307

This HCPCS code represents 1 mg of pralatrexate injection.

2025 HCPCS code J9175

J9175 represents 1 mL of Elliotts' B solution, a sterile isotonic diluent used for intrathecal drug administration.